Therapeutic and prophylactic effect of flavonoids in post-COVID-19 therapy

Phytother Res. 2022 May;36(5):2042-2060. doi: 10.1002/ptr.7436. Epub 2022 Mar 18.

Abstract

The high incidence of post-covid symptoms in humans confirms the need for effective treatment. Due to long-term complications across several disciplines, special treatment programs emerge for affected patients, emphasizing multidisciplinary care. For these reasons, we decided to look at current knowledge about possible long-term complications of COVID-19 disease and then present the effect of flavonoids, which could help alleviate or eliminate complications in humans after overcoming the COVID-19 infection. Based on articles published from 2003 to 2021, we summarize the flavonoids-based molecular mechanisms associated with the post-COVID-19 syndrome and simultaneously provide a complex view regarding their prophylactic and therapeutic potential. Review clearly sorts out the outcome of post-COVID-19 syndrome according particular body systems. The conclusion is that flavonoids play an important role in prevention of many diseases. We suggest that flavonoids as critical nutritional supplements, are suitable for the alleviation and shortening of the period associated with the post-COVID-19 syndrome. The most promising flavonoid with noteworthy therapeutic and prophylactic effect appears to be quercetin.

Keywords: SARS-CoV-19; antiinflammatory; flavonoids; post-COVID-19 syndrome.

Publication types

  • Review

MeSH terms

  • COVID-19 Drug Treatment*
  • COVID-19* / complications
  • Flavonoids / pharmacology
  • Flavonoids / therapeutic use
  • Humans
  • Post-Acute COVID-19 Syndrome
  • SARS-CoV-2

Substances

  • Flavonoids

Grants and funding